SREBP1 and Its Partners Regulate Genes Involved in Metabolism
Author Information
Author(s): Reed Brian D., Charos Alexandra E., Szekely Anna M., Weissman Sherman M., Snyder Michael
Primary Institution: Yale University
Hypothesis
The study aims to identify the target genes of SREBP1 and its partners NFY and SP1 in human liver cells and understand their regulatory roles.
Conclusion
The study reveals that SREBP1, along with NFY and SP1, occupies the promoters of 1,141 target genes, significantly influencing lipid metabolism and insulin signaling.
Supporting Evidence
- SREBP1 occupies the promoters of 1,141 target genes involved in diverse biological pathways.
- Many SREBP1 target genes are transcriptionally activated by treatment with insulin and glucose.
- SREBP1 cooperates extensively with NFY and SP1 throughout the genome.
- The binding sites identified are likely to have a functional role in vivo.
Takeaway
This study shows that a protein called SREBP1 helps control many genes that manage how our body uses fats and sugars, especially when we eat.
Methodology
The researchers used chromatin immunoprecipitation combined with genome tiling arrays (ChIP-chip) to identify SREBP1 target genes in HepG2 cells.
Statistical Information
P-Value
1.4×10−29
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website